...
首页> 外文期刊>International immunopharmacology >Diabetes modulates the expression of glomerular kinin receptors.
【24h】

Diabetes modulates the expression of glomerular kinin receptors.

机译:糖尿病调节肾小球激肽受体的表达。

获取原文
获取原文并翻译 | 示例

摘要

The localization of kinin receptors within the kidney implicates this system in the regulation of glomerular hemodynamics. We reported that diabetes alters the activity of the renal kallikrein-kinin system, and that these alterations contribute to the development of microvascular complications of diabetes. The present study examined the influence of diabetes on the expression of glomerular B1 and B2-kinin receptors, and assessed the cellular signaling of kinin receptor activation. Rats made diabetic with streptozocin (85 mg/kg), displayed plasma glucose levels in the range of 350-500 mg/dl. At 3, 7, and 21 days, B1 and B2-kinin receptor mRNA levels were measured in isolated glomeruli from control and diabetic rats by RT-PCR. Glomeruli revealed a differential pattern of expression between the two kinin receptors. The constitutively expressed B2-receptor was increased three-fold at day 3, but returned to normal levels at day 7; whereas, the inducible B1-receptor was maximally expressed (20-fold) at day 7and remained elevated (10-fold) at day 21. To test whether the induction of kinin receptors by diabetes translates into increased responsiveness, we measured mitogen-activated protein kinase (MAPK) phosphorylation (p42, p44) in glomeruli isolated from control and diabetic rats stimulated with B1-receptor agonist (des-Arg9-bradykinin, 10(-8) M). A three-fold increase in phosphorylation of MAPK was observed in response to B1-receptor agonist challenge in glomeruli isolated form diabetic rats compared to controls. These findings demonstrate for the first time that glomerular kinin receptors are induced by diabetes, and provide a rationale to study the contribution of these receptors to the development of glomerular injury in diabetes.
机译:肾激肽受体的定位在肾小球血流动力学的调节中牵涉该系统。我们报道了糖尿病改变了肾激肽释放酶激肽系统的活性,并且这些改变促进了糖尿病微血管并发症的发展。本研究检查了糖尿病对肾小球B1和B2-激肽受体表达的影响,并评估了激肽受体激活的细胞信号传导。用链佐星(85 mg / kg)制成糖尿病大鼠,血浆葡萄糖水平在350-500 mg / dl范围内。在第3、7和21天,通过RT-PCR测量了来自对照和糖尿病大鼠的分离的肾小球中的B1和B2-激肽受体mRNA水平。肾小球揭示了两种激肽受体之间的差异表达模式。组成型表达的B2受体在第3天增加了3倍,但在第7天恢复了正常水平。然而,诱导型B1受体在第7天最大表达(20倍),在第21天保持升高(10倍)。为了测试糖尿病对激肽受体的诱导是否转化为反应性增强,我们测量了促分裂原活化蛋白从B1受体激动剂(des-Arg9-缓激肽,10(-8)M)刺激的对照组和糖尿病大鼠肾小球中分离出肾小球中的激酶(MAPK)磷酸化(p42,p44)。与对照相比,在糖尿病大鼠分离的肾小球中,响应于B1受体激动剂攻击,观察到MAPK磷酸化增加了三倍。这些发现首次证明了糖尿病引起的肾小球激肽受体,为研究这些受体对糖尿病肾小球损伤发展的贡献提供了理论依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号